SDC1 and central nervous system cancer: In addition to CS, it is well known that HS and HS-modified proteoglycans (HSPGs), such as syndecan and glypican, are expressed in melanoma, breast cancer, glioma, and hepatocellular carcinoma and are related to cancer growth and metastasis (20, 21).